Successful treatment with tacrolimus of refractory adult-onset Still's disease

Korean J Intern Med. 2014 Mar;29(2):259-61. doi: 10.3904/kjim.2014.29.2.259. Epub 2014 Feb 27.

Authors

Masashi Ohe¹, Kenji Oku², Michihito Kono², Toshiyuki Bohgaki²

Affiliations

¹ Department of General Medicine, Hokkaido Social Insurance Hospital, Sapporo, Japan.
² Department of Medicine II, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

No abstract available

Keywords: Interleukin-18; Still's disease, adult-onset; Tacrolimus.

Publication types

Case Reports

MeSH terms

Cyclosporine / therapeutic use*
Drug Resistance*
Drug Substitution
Drug Therapy, Combination
Female
Humans
Immunosuppressive Agents / therapeutic use*
Middle Aged
Prednisolone / therapeutic use
Still's Disease, Adult-Onset / blood
Still's Disease, Adult-Onset / diagnosis
Still's Disease, Adult-Onset / drug therapy*
Still's Disease, Adult-Onset / immunology
Tacrolimus / therapeutic use*
Time Factors
Treatment Outcome

Substances

Immunosuppressive Agents
Cyclosporine
Prednisolone
Tacrolimus